Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 12, 1999, Pages 1286-1292

  Katoh, Shigeki ^a   Taniguchi, H ^a   Matsubara, Y ^b   Matsumoto, N ^a   Fukushima, K ^c   Kadota, J ^b   Matsukura, S ^a   Kohno, S ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nagasaki Prefecture Tarami Hospital   (Japan)

Author keywords

Bronchoalveolar lavage fluid; CD44; Eosinophil; Eosinophilic pneumonia; Human; Hyaluronic acid; Interleukin 5

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 5;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; PRIORITY JOURNAL; CYTOLOGY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ANTIGENS, CD44; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; FEMALE; HUMANS; HYALURONIC ACID; INTERLEUKIN-5; MALE; MIDDLE AGED; PULMONARY EOSINOPHILIA;

EID: 0033251036     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00277.x     Document Type: Article

References (29)

1. 1. Liebow AA, Carrington CB. The eosinophilic pneumonias. Medicine 1969;48:251-255.
2. 2. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-1118.
3. 3. Tominaga A, Takaki S, Koyama N, et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J Exp Med 1991;173:429-437.
4. 4. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-224.
5. 5. Walker C, Bauer W, Braun RK, et al. Activated T cells and cytokines in bronchoalveolar lavage from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150:1038-1048.
6. 6. Allen JN, Liao Z, Wewers MD, Altenberger EA, Moore SA, Allen ED. Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia. J Allergy Clin Immunol 1996;97:1366-1374.
7. 7. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1β-induced transendothelial migration. J Immunol 1992;149:4021-4028.
8. 8. Bochner BS, Luscinskas FW, Gimbrone MA, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contribution of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-1556.
9. 9. Pretolani M, Ruffie C, Silva JL, Joseph D, Lobb RR, Vargaftig BB. Antibody to late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 1994;180:795-805.
10. 10. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with the extracellular matrix. Adv Immunol 1993;54:271-335.
11. 11. Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 1988;141:1615-1623.
12. 12. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672-675.
13. 13. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172:69-75.
14. 14. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
15. 15. Kincade PW, Zheng Z, Katoh S, Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr Opin Cell Biol 1997;9:635-642.
16. 16. Murakami S, Miyake K, Abe R, Kincade PW, Hodges RJ. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol 1990;145:3618-3627.
17. 17. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995;182:419-429.
18. 18. Matsumoto K, Appiah-Pippim J, Schleimer RP, Bickel CA, Beck LA, Bochner BS. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol 1993;18:860-866.
19. 19. Webb DSA, Shimizu Y, Seventer GAV, Shaw S, Gerrard TL. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 1990;249:1295-1297.
20. 20. Kadota J, Matsubara Y, Ishimatsu Y, et al. Significance of IL-1β and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol 1996;103:461-466.
21. 11. Azuma M, Nakamura Y, Sano T, Okano Y, Sone S. Adhesion molecule expression on eosinophils in idiopathic eosinophilic pneumonia. Eur Respir J 1996;9:2494-2500.
22. 22. Katoh S, McCarthy JB, Kincade PW. Characterization of soluble CD44 in the circulation of mice: levels are affected by immune activity and tumor growth. J Immunol 1994;153:3440-3449.
23. 23. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 1993;122:257-264.
24. 24. Pericle F, Sconocchia G, Titus JA, Segal DM. CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol 1996;157:4657-4663.
25. 25. Venge J, Lampinen M, Håkansson L, Rak S, Venge P. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 1996;97:1110-1115.
26. 26. Sano K, Yamauchi K, Hoshi H, Honma M, Tamura G, Shirato K. CD44 on blood eosinophils as a novel marker of bronchial asthma management. Allergol Int 1998;47:29-35.
27. 27. Noble PW, Lake FR, Henson PM, Riches DWH. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J Clin Invest 1993;91:2368-2377.
28. 28. Charlotte MM, Penno MB, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J Clin Invest 1996;98:2403-2413.
29. 29. Hamann KJ, Dowling TL, Neeley SP, Grant JA, Leff AR, Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol 1995;154:4073-4080.